Skip to main content
Signal8

Medtronic plc (MDT)

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Medical - Devices

Medtronic plc logo

Medtronic plc

NYSE:MDTHealthcare
-1.22%$95.41
AH Close$95.41+0.00%vs close
Mkt Cap$122.04B
Float1.28B
O/S1.28B
Inst Own83.5%
SI3.1%
Div Yield3.00%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$122.04B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership83.47%

based on 1.28B shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE
CountryIEIE
IPO Date-
Shares Outstanding1.28B
Float1.28B
Company Overview

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world.

The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software.

It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment.

It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts.

Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Leadership

Geoff Martha

Chairman and Chief Executive Officer

Geoffrey (Geoff) Martha

Chairman and Chief Executive Officer

Michael (Mike) Marinaro

Executive Vice President and President, Medical Surgical Portfolio and Americas

Michelle Quinn

Executive Vice President, General Counsel & Secretary

Employees

95K+

Country

IE

Sector

Healthcare

Website

medtronic.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
30
HOLD
21
SELL
0
TOTAL51
Insider Trading
InsiderTypeShares
Martha Geoffrey profile photoMartha GeoffreySale50.0K
Marinaro Michael profile photoMarinaro MichaelSale10.4K
Lofton Kevin E profile photoLofton Kevin EOther182
KIIL HARRY SKIP profile photoKIIL HARRY SKIPSale1.5K
Blomquist Denise L. profile photoBlomquist Denise L.Withholding/Transfer600
Marinaro Michael profile photoMarinaro MichaelAutomatic Sell1.1K
Shareholders
83.5%
Institutional
(2187)
0.1%
Insiderⓘ
(26)
0.0%
5%+ Owners
(0)
16.4%
Unattributed (incl. retail)ⓘ
Institutional83.5%
Insider0.1%
Unattributed (incl. retail)16.4%
Sources: 13F, Form 4, 13D/13GO/S: 1.3B · as of 28 Aug 2026 · SEC cover page
Insiders & Institutional Holders

Insiders

52-Week Range
$73.31$106.33
$95.41(67th percentile)
Volume
Average Daily Volume34.28M
6.01M today vs 34.28M avg(-82%)

30d Avg

34.28M

60d Avg

21.77M

90d Avg

16.65M

Earnings
Dividend History
TTM Yield
3.00%
Paid quarterly
Annual (LTM)
$2.86
Latest
$0.7200
Sep 25, 26
5Y Growth
+3.40%
per year
Compliance Status
Loading compliance data...